It is currently known that Sirt1‐Fox1, PI3K‐Akt and other signalling pathways can inhibit OS and apoptosis in cardiomyocytes, thereby achieving the purpose of remission and treatment of DCM. This evidence concerns the gene AKT1 and familial dilated cardiomyopathy.